Pvg Asset Management Corp Cardiol Therapeutics Inc. Transaction History
Pvg Asset Management Corp
- $17.7 Million
- Q4 2024
A detailed history of Pvg Asset Management Corp transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Pvg Asset Management Corp holds 487,295 shares of CRDL stock, worth $638,356. This represents 3.54% of its overall portfolio holdings.
Number of Shares
487,295Holding current value
$638,356% of portfolio
3.54%Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
7.58MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$4.08 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$1.16 Million0.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$1.04 Million0.31% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$432,9610.0% of portfolio
-
Envestnet Asset Management Inc310KShares$405,6860.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $81.1M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...